Calcium channels in glioma

Abstract

Liu Yang, Wamg Yanming. Calcium channels in glioma[J]. Journal of International Oncology, 2014, 41(8): 579-582.

［1］ Prevarskaya N, Skryma R, Shuba Y. Targeting Ca2+ transport in cancer: close reality or long perspective?［J］. Expert Opin Ther Targets, 2013, 17(3): 225-241. ［2］ Taylor JT, Zeng XB, Pottle JE, et al. Calcium signaling and Ttype calcium channels in cancer cell cycling［J］. World J Gastroenterol, 2008, 14(32): 4984-4991. ［3］ Lu F, Chen H, Zhou C, et al. Ttype Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation［J］. Cell Calcium, 2008, 43(1): 4958. ［4］ Ohkubo T, Yamazaki J. Ttype voltageactivated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF7 human breast cancer cells［J］. Int J Oncol, 2012, 41(1): 267-275. ［5］ Li W, Zhang SL, Wang N, et al. Blockade of Ttype Ca2+ channels inhibits human ovarian cancer cell proliferation［J］. Cancer Invest, 2011, 29(5): 339-346. ［6］ Zhang Y, Zhang J, Jiang D, et al. Inhibition of Ttype Ca2+ channels by endostatin attenuates human glioblastoma cell proliferation and migration［J］. Br J Pharmacol, 2012, 166(4): 1247-1260. ［7］ Valerie NC, Dziegielewska B, Hosing AS, et al. Inhibition of Ttype calcium channels disrupts Akt signaling and promotes apoptosis in glioblastoma cells［J］. Biochem Pharmacol, 2013, 85(7): 888-897. ［8］ Sheehan JP, Xu Z, Popp B, et al. Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery［J］. J Neurosurg, 2013, 118(4): 830-837. ［9］ Keir ST, Friedman HS, Reardon DA, et al. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model［J］. J Neurooncol, 2013, 111(2): 97-102. ［10］ Santoni G, Farfariello V. TRP channels and cancer: new targets for diagnosis and chemotherapy［J］. Endocr Metab Immune Disord Drug Targets, 2011, 11(1): 54-67. ［11］ Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer［J］. Biochim Biophys Acta, 2007, 1772(8): 937-946. ［12］ Gkika D, Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis［J］. Biochim Biophys Acta, 2009, 1793(6): 953-958. ［13］ Santoni G, Farfariello V, Amantini C. TRPV channels in tumor growth and progression［J］. Adv Exp Med Biol, 2011, 704: 947-967. ［14］ Bomben VC, Sontheimer HW. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas［J］. Cell Prolif, 2008, 41(1): 98-121. ［15］ Bomben VC, Sontheimer H. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas［J］. Glia, 2010, 58(10): 1145-1156. ［16］ Malarkey EB, Ni Y, Parpura V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes［J］. Glia, 2008, 56(8): 821-835. ［17］ Ding X, He Z, Zhou K, et al. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma［J］. J Natl Cancer Inst, 2010, 102(14): 1052-1068. ［18］ Chigurupati S, Venkataraman R, Barrera D, et al. Receptor channel TRPC6 is a key mediator of Notchdriven glioblastoma growth and invasiveness［J］. Cancer Res, 2010, 70(1): 418-427. ［19］ Amantini C, Mosca M, Nabissi M, et al. Capsaicininduced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation［J］. J Neurochem, 2007, 102(3): 977-990. ［20］ Stock K, Kumar J, Synowitz M, et al. Neural precursor cells induce cell death of highgrade astrocytomas through stimulation of TRPV1［J］. Nat Med, 2012, 18(8): 1232-1238. ［21］ Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fasinduced apoptosis in ERKdependent manner［J］. Carcinogenesis, 2010, 31(5): 794-803. ［22］ Nabissi M, Morelli MB, Santoni M, et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents［J］. Carcinogenesis, 2013, 34(1): 48-57.

[1]	Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197.
[2]	Xiao Nan, Sun Pengfei.Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas[J]. Journal of International Oncology, 2022, 49(6): 357-361.
[3]	Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao.Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients[J]. Journal of International Oncology, 2022, 49(2): 79-83.
[4]	Kong Chunyu, Sun Pengfei.SLC7A11 and glioma[J]. Journal of International Oncology, 2022, 49(10): 604-607.
[5]	Guo Shihao, Ren Yeqing, Guo Geng.Molecular mechanism of vasculogenic mimicry in brain glioma[J]. Journal of International Oncology, 2021, 48(6): 362-365.
[6]	Wang Xianwei, Shi Meiyan, Wang Fengqin, Qi Fu, Wang Chaozhe, Zhou Fei.Roles of TSA upregulation miR-4298 targeting inhibition of PADI4 expression in inducing U251 cells apoptosis[J]. Journal of International Oncology, 2021, 48(4): 193-199.
[7]	Sun Yanqi, Ren Yeqing, Guo Geng.Mechanism of inhibitory effect of interferon and its related signal pathway on the invasion of glioma[J]. Journal of International Oncology, 2021, 48(3): 172-175.
[8]	Zhao Congxuan, Yu Tao.Mining and prediction of glioma-related genes[J]. Journal of International Oncology, 2020, 47(5): 293-296.
[9]	Nan Yang, Zhong Yue.New research advances of long non-coding RNA in glioma[J]. Journal of International Oncology, 2020, 47(2): 98-102.
[10]	Zhang Wen, Song Qibin, Hu Weiguo.Clinical application of multimodal magnetic resonance imaging in glioma[J]. Journal of International Oncology, 2020, 47(11): 686-690.
[11]	Chen Liang, Qin Jun, Lei Junrong, Liu Jun, Wang Lu.miR-1254 inhibits the proliferation and invasion of glioma cells by targeting CSF-1[J]. Journal of International Oncology, 2020, 47(10): 577-584.
[12]	Zhang Qianhui, Zhang Yang, Su Weipeng, Zhang Song′an, Liu Pan, Zhao Huarong.Expressions of LSD1, MGMT and Ki-67 in high-grade glioma and their influences on prognosis[J]. Journal of International Oncology, 2019, 46(9): 519-525.
[13]	Yi Lin, Qiu Shi.Anti-tumor effect and mechanisms of shikonin on gliomas[J]. Journal of International Oncology, 2019, 46(8): 489-491.
[14]	Yu Xuejuan, An Hongwei, Sun Yamei, Jiang Zheng, Zhang Xuehai, Yang Wenjing, Zhang Wei.Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance[J]. Journal of International Oncology, 2019, 46(12): 718-722.
[15]	Lu Di, Zhang Jundong, Guo Geng, Wang Xiaogang.Research progress of interferon induced glioma cell apoptosis[J]. Journal of International Oncology, 2018, 45(7): 432-435.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments